Jamie Heywood

Jamie Heywood is a distinguished leader in the healthcare and biotechnology sectors, currently serving as the CEO and Founder of Alden Scientific, which focuses on First-Principles-Based Digital Biology. With a strong commitment to health outcomes, Jamie is a Board Member at the International Consortium for Health Outcomes Measurement (ICHOM) and contributes to the advisory council of the Center for the Neuroscience of Psychedelics at Harvard Medical School and Massachusetts General Hospital. Jamie's extensive experience includes strategic advisory roles at Arcadia Medicine Inc., co-founding and board positions at AoBiome and Everyone.org, as well as foundational involvement with the ALS Therapy Development Institute. Previously, Jamie co-founded PatientsLikeMe, serving as CEO and Chairman, and held the position of Chief Research Officer at iCarbonX. Jamie holds an SB in Mechanical Engineering from the Massachusetts Institute of Technology.